Come up with a name for your new list and we'll add to it:
Adaptive Phage Therapeutics raised a round of funding on April 14, 2017. Investors include
Maryland Technology Development Corporation.
Adaptive Phage Therapeutics (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. Two key compone…